ANTIEPILEPTIC DRUG DEVELOPMENT PROGRAM

被引:501
作者
PORTER, RJ
CEREGHINO, JJ
GLADDING, GD
HESSIE, BJ
KUPFERBERG, HJ
SCOVILLE, B
WHITE, BG
机构
来源
CLEVELAND CLINIC QUARTERLY | 1984年 / 51卷 / 02期
关键词
D O I
10.3949/ccjm.51.2.293
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:293 / 305
页数:13
相关论文
共 15 条
  • [1] [Anonymous], ARCH EXP PATHOL PHAR
  • [2] CHEN G, 1951, J PHARMACOL EXP THER, V103, P54
  • [3] GOODMAN LS, 1953, J PHARMACOL EXP THER, V108, P168
  • [4] Hauptmann A., 1912, Munich Medicine. Wochenschr, V59, P1907
  • [5] Locock C., 1857, The Lancet, V70, P527
  • [6] MATTSON RH, 1983, NEUROLOGY, V33, P1
  • [7] A new series of anticonvulsant drugs tested by experiments on animals
    Merritt, HH
    Putnam, TJ
    [J]. ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1938, 39 (05): : 1003 - 1015
  • [8] Sodium diphenyl hydantoinate in the treatment of convulsive disorders
    Merritt, HH
    Putnam, TJ
    [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1938, 111 : 1068 - 1073
  • [9] Richards R.K., 1944, FED PROC, V3, P39
  • [10] Spiegel EA, 1937, J LAB CLIN MED, V22, P1274